Tempus Lens
Agentic platform for oncology drug development that assembles patient cohorts, simulates trials and generates regulatory evidence from Tempus's real-world dataset.
Find alternatives to Tempus Lens
Sold as a biopharma partnership — licence models, licence datasets, or embed Lens with Tempus scientists; no list price is published.
What it does
- Agent orchestration
- Drug discovery
- Data analysis
Sources
- Pricing
-
Official documentation · 25 Aug 2026
The 'Ways to partner' section lists licensing and embedded-team engagements; no list price is published, and tempus.com answers 429 to automated requests so the page was read in a browser.
- Sold within
-
Tempus calls Lens "the agentic platform for oncology drug development"; the page offers "CONTACT US", a "LOG IN" link and a feasibility request, noting "All feasibility requests are subject to Tempus’ internal review and approval." No plan, price or self-serve sign-up is stated.
Also from Tempus AI
-
Tempus precision medicine platform Application
Clinical and genomic data platform that sequences patient samples and returns results to oncologists.
-
Tempus ECG-AF Application
AI algorithm that identifies ECG signs associated with future atrial fibrillation risk.
-
Tempus ECG-Low EF Application
AI algorithm that identifies ECG signs associated with low ejection fraction (heart-failure risk).
Open Tempus AI in the directory
Something wrong here? Send a correction — quote this product id: tempus-lens.